.webp)
A deal review is a structured examination of a single opportunity: what is actually known about it, what is being assumed, and what would need to be true for it to close on the date in the forecast. Done properly it is uncomfortable, because its purpose is to find the weakness rather than to confirm the plan. This article sets out the six questions that do most of the work, who should be in the room, which deals deserve the time, and why so many reviews degrade into status readouts within a quarter.
How many deals in your current forecast have been reviewed by someone whose job was to find the flaw rather than to agree?
The bottom line: a deal review works only if it separates what the buyer said from what the rep believes. Most reviews collapse because they ask what is happening on the deal, which invites a narrative, instead of asking what evidence exists for each claim, which invites a fact. The single most productive question in the format is also the least popular one: what would have to be true for this to close, and do we know that it is?
Deal review, pipeline review, forecast call
Three meetings routinely merge into one, and the merger is why none of them works. A pipeline review scans the whole portfolio: coverage, distribution across stages, forecast accuracy. A forecast call commits to numbers. A deal review goes deep on one opportunity and should reach a verdict about its qualification rather than its probability percentage.
The distinction is practical. As Everstage notes in its guidance on sales performance reviews, monthly pipeline reviews serve to analyse deal stages and clear stalled opportunities to keep data clean. That is portfolio hygiene. It is a different exercise from interrogating a single deal, and putting both on the same agenda means the second never happens.
The six questions
| Question | What a weak answer sounds like |
|---|---|
| What has the buyer said that proves this is a priority? | They seem very interested |
| Who signs, and have we spoken to them directly? | Our contact will handle it internally |
| What are the exact steps between today and signature? | They said it should move quickly |
| What is the alternative we are being compared to? | I do not think they are looking at anyone else |
| What would have to be true for this to close on that date? | Nothing, it is on track |
| What has changed since the last review? | Nothing much |
The right-hand column is the point. Each weak answer is a belief presented as a fact, and each one is the seed of a deal that slips a quarter. A manager who does nothing more than ask for the evidence behind each claim will change forecast accuracy faster than any new process.
Which deals deserve one
Not all of them, and this is where most teams overreach. Reviewing every open opportunity every week teaches reps to prepare summaries rather than to think, and consumes the attention that the genuinely uncertain deals needed. Three triggers justify the time: size relative to your average, strategic importance beyond the revenue, and a specific warning sign such as a close date that has already moved once, a champion who has gone quiet, or a competitor appearing late.
That third category is the most valuable and the most often missed, because it requires someone to notice the signal. A slipped close date is visible in the CRM; a champion going quiet usually is not.
Who should be in the room
The rep, their manager, and whoever owns the technical evaluation when there is one. Beyond four people the format changes character: the rep starts presenting rather than thinking, and the review becomes a performance. Senior leadership attendance has the same effect, which is why executive presence belongs in forecast calls rather than deal reviews.
The manager's role deserves a definition, because it is usually left implicit. It is not to help win the deal in the meeting. It is to establish whether the deal is qualified, and to be willing to say it is not. Where that willingness is missing, the review documents opportunities nobody intends to disqualify, a failure mode we cover in the MEDDIC sales process.
Why reviews degrade
- They are scheduled but not prepared, so the first twenty minutes reconstruct context everyone should have had in advance.
- They accept narrative as evidence, which rewards the reps who tell the best story.
- They produce no decision, so the same deal returns unchanged the following month.
- They rely on CRM records too incomplete to challenge anything, which makes the rep's account the only available version of events.
The last point is structural. A review can only interrogate what is written down, so the quality of the record sets the ceiling on the quality of the conversation, and the same scorecard inputs that make rep evaluation credible make deal reviews possible at all.
Reviewing deals against what was actually said
The recurring obstacle is that a deal review interrogates a record written by the person being questioned. Praiz changes the source. Every call is recorded, transcribed and analysed by specialized agents: the MEDDICC Summary agent extracts what the buyer explicitly stated about each qualification criterion and writes it to the matching CRM fields, the Objection Tracker logs what was raised and left unresolved, the Competitors Tracker captures alternatives mentioned in passing. A manager preparing a review opens the account and sees the buyer's own words rather than a summary, and the six questions above become answerable from evidence. Praiz customer teams report a 90% improvement in the reliability of strategic CRM fields. Criteria are configured to your process in the Praiz AI agents library, with onboarding support rather than a blank page, and the underlying data quality problem gets solved at the source.
See it in action
Review deals on evidence, not on recollection
Praiz writes what the buyer actually said into your CRM, so every deal review starts from facts instead of a narrative.
Frequently asked questions
What is the difference between a deal review and a pipeline review?
A deal review examines one opportunity in depth: what is known, what is assumed, and what would have to be true for it to close.
A pipeline review scans the whole portfolio for coverage and forecast accuracy. Confusing them turns a two-hour meeting into a status readout.
Which deals deserve a review?
Deals that are large, strategic, or showing a specific warning sign such as a slipped close date or a champion who has gone quiet.
Reviewing every deal every week trains the team to prepare summaries rather than to think.
Why do deal reviews become useless?
Because they ask what has changed rather than what is known, and accept the rep's account as evidence.
A review that never disqualifies anything is a status meeting wearing a different name.
